ZEMYNA BRINGS YOU CARTISTEM.

A ground-breaking treatment for knee cartilage damage in patients with osteoarthritis as a result of degenerative disease or repeated trauma. CARTISTEM® is currently the only approved “Stem Cell Therapy Product” in the world for the regeneration of knee cartilage.

Zemyna partners with International St. Mary’s Hospital in Incheon-Seoul, Korea to provide CARTISTEM® treatment to patients from all over the world. Over 12 years of R&D and multiple clinical trials conducted in Korea demonstrated a 98% success rate in regeneration of cartilage of the knee resulting in significant pain reduction and improved function and mobility.

Approved product-label by the Korean Regulatory Authority (MFDS) CARTISTEM® reads:

“CARTISTEM® is indicated for the treatment of articular cartilage defects in patients with osteoarthritis (ICRS grade IV) as a result of degenerative disease or repeated trauma.”

From your approval for surgery to your recovery there are nine easy steps involved in CARTISTEM treatment.